Improvement of psoriatic arthritis by pioglitazone treatment in a type 2 diabetic patient

Diabetes Res Clin Pract. 2010 Oct;90(1):e9-e10. doi: 10.1016/j.diabres.2010.05.020. Epub 2010 Jun 17.

Authors

M Takahara, T Shiraiwa, H Kaneto, T Yasuda, A Kuroda, F Sakamoto, T Naka, K Miyashita, K Sakamoto, T Matsuoka, I Shimomura, M Matsuhisa

PMID: 20816261
DOI: 10.1016/j.diabres.2010.05.020

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Arthritis, Psoriatic / blood
Arthritis, Psoriatic / complications*
Arthritis, Psoriatic / drug therapy*
C-Reactive Protein / analysis
Diabetes Mellitus, Type 2 / blood
Diabetes Mellitus, Type 2 / complications*
Diabetes Mellitus, Type 2 / drug therapy*
Female
Glycated Hemoglobin / analysis
Humans
Hypoglycemic Agents / therapeutic use*
Insulin Resistance
Middle Aged
Oxidative Stress / drug effects
Pioglitazone
Severity of Illness Index
Thiazolidinediones / therapeutic use*

Substances

Glycated Hemoglobin A
Hypoglycemic Agents
Thiazolidinediones
hemoglobin A1c protein, human
C-Reactive Protein
Pioglitazone